它既能切割,又能切割:一个单中心的回顾性综述描述了克洛西林,沃里科纳和塔克罗利斯之间的三方相互作用
Fay S Burrows1, Lilibeth M Carlos1, Jana Stojanova2
1Pharmacy Department, St. Vincent's Hospital, Sydney, NSW, 2010, Australia.
International journal of antimicrobial agents
|June 29, 2023
概括
富洛克萨西林显著降低了沃里康纳的水平,在移植患者中需要更高的塔克罗利斯剂量. 避免使用弗洛克西林和沃里康纳,并在使用期间和使用后密切监测塔克罗利.
科学领域:
- 药理学 药理学是指药理学的学科.
- 药物相互作用 药物相互作用
- 移植医学 移植医学 移植医学
背景情况:
- 塔克罗利斯是一种狭窄的治疗指数药物,是CYP3A4基质.
- 沃里科纳是一种强大的CYP3A4抑制剂,需要调整塔克罗利斯的剂量.
- 已知富洛克萨西林可以单独降低塔克罗利斯和沃里康纳的度.
研究的目的:
- 为了研究克洛西林,伏利可纳和塔克罗利斯之间的三向相互作用.
- 评估克洛西林对移植受体中沃里科纳和塔克罗利斯度的影响.
主要方法:
- 药物度和剂量调整的回顾性审查.
- 分析了8名移植接受者,他们同时接受流沙林,伏利可纳和塔克罗利斯.
主要成果:
- 在所有患者中,Flucloxacillin的使用导致了亚治疗性voriconazole度.
- 为了保持治疗水平,需要大幅增加塔克罗利斯总每日剂量.
- 在停止用弗洛克西林后,塔克罗利斯水平变得超治疗性,需要降低剂量.
结论:
- 弗卢克洛沙林,伏利可纳和塔克罗利斯之间存在显著的三向药物相互作用.
- 应避免同时使用弗洛克洛西林和沃里科纳.
- 密切监测和调整塔克罗利斯的剂量在治疗期间和之后都至关重要.
相关概念视频
Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids
156
Glucocorticoids, a class of anti-inflammatory drugs, are pivotal in treating moderate to severe Crohn's disease by inducing remission. They exhibit their anti-inflammatory action by inhibiting the production of inflammatory cytokines such as tumor necrosis factor (TNF)-α, interleukin (IL)-1, and chemokines like IL-8. In addition, they reduce the expression of inflammatory cell adhesion molecules and inhibit gene transcription of nitric oxide synthase, phospholipase A2, cyclooxygenase-2...
156
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
200
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
200
Combined Effects of Drugs: Synergism
4.1K
Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
Such synergistic combinations...
4.1K
Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
175
Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab...
175
Factors Affecting Renal Clearance: Drug Distribution and Drug Interactions
175
Renal clearance plays a pivotal role in drug elimination from the body and can be influenced by drug distribution and interactions. Understanding these factors is crucial in pharmacology as they impact the effectiveness and duration of drug therapy.
One important factor is the relationship between renal clearance and the apparent volume of distribution. Renal clearance tends to be inversely proportional to the apparent volume of distribution. Drugs with an extensive distribution volume or those...
One important factor is the relationship between renal clearance and the apparent volume of distribution. Renal clearance tends to be inversely proportional to the apparent volume of distribution. Drugs with an extensive distribution volume or those...
175
Factors Affecting Protein-Drug Binding: Drug Interactions
202
Drug interactions are a critical aspect of pharmacology and can occur when two or more drugs compete for the same binding site. This competition can result in one drug displacing another, altering the effect of the displaced drug. Drug interactions are complex processes that rely heavily on how much of the displacer drug is present and how strongly it can bind to the same sites as the displaced drug.
Displacement interactions can have varying outcomes, ranging from toxicity to virtually...
Displacement interactions can have varying outcomes, ranging from toxicity to virtually...
202


